A phase 3 non-inferiority study of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study-Reference-Cited by-同舟云学术

A phase 3 non-inferiority study of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study

Published:2014-08-09 Issue:1 Volume:141 Page:153-160
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Yasui Hirofumi,Muro Kei,Shimada Yasuhiro,Tsuji Akihito,Sameshima Shinichi,Baba Hideo,Satoh Taroh,Denda Tadamichi,Ina Kenji,Nishina Tomohiro,Yamaguchi Kensei,Esaki Taito,Tokunaga Shinya,Kuwano Hiroyuki,Boku Narikazu,Komatsu Yoshito,Watanabe Masahiko,Hyodo Ichinosuke,Morita Satoshi,Sugihara Kenichi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-014-1783-3.pdf

Reference17 articles.

1. Baba H, Watanabe M, Okabe H et al (2012) Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer. Br J Cancer 107:1950–1955

2. Brookmeyer R, Crowley J (1982) A confidence interval for the median survival time. Biometrics 38:29–41

3. Fuse N, Doi T, Ohtsu A et al (2008) Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancer. Int J Clin Oncol 13:144–149

4. Goto A, Yamada Y, Yasui H et al (2006) Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer. Ann Oncol 17:968–973

5. Komatsu Y, Yuki S, Fuse N et al (2010) Phase 1/2 clinical study of irinotecan and oral S-1 (IRIS) in patients with advanced gastric cancer. Adv Ther 27:483–492

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review and non-inferiority meta-analysis of randomised phase II/III trials on S-1-based therapy versus 5-fluorouracil- or capecitabine-based therapy in the treatment of patients with metastatic colorectal cancer;European Journal of Cancer;2022-05

2. FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial;Therapeutic Advances in Medical Oncology;2022-01

4. Oral drugs in the treatment of metastatic colorectal cancer;Therapeutic Advances in Medical Oncology;2021-01

5. Analysis of pemetrexed-based chemotherapy in the treatment of advanced colorectal cancer;Annals of Translational Medicine;2020-11